The molecular pathology of rosacea

Journal of Dermatological Science

Volumn 55, Issue 2, 2009, Pages 77-81

  Yamasaki, Kenshi ^a,b   Gallo, Richard L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Cathelicidin; Demodex; Immunity; Innate; Kallikrein; Matrix mettaloproteinase; Protease; Reactive oxygen species; Rosacea; Ultra violet light

Indexed keywords

AZELAIC ACID; AZITHROMYCIN; CATHELICIDIN; ERYTHROMYCIN; METRONIDAZOLE; PROTEINASE; REACTIVE OXYGEN METABOLITE; RETINOID; TETRACYCLINE DERIVATIVE;

ANTIOXIDANT ACTIVITY; CLINICAL OBSERVATION; DEMODEX; DEMODEX FOLLICULORUM; DRUG EFFICACY; ENVIRONMENTAL FACTOR; HELICOBACTER PYLORI; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; ROSACEA; SKIN INFLAMMATION; SUN EXPOSURE; ULTRAVIOLET RADIATION; VASCULAR DISEASE;

ANIMALS; BACTERIAL INFECTIONS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; MITE INFESTATIONS; OXIDATIVE STRESS; PEPTIDE HYDROLASES; REACTIVE OXYGEN SPECIES; RISK FACTORS; ROSACEA; SIGNAL TRANSDUCTION; SKIN; ULTRAVIOLET RAYS;

EID: 67649774232     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2009.04.007     Document Type: Review

References (77)

1. Del Rosso J.Q. Update on rosacea pathogenesis and correlation with medical therapeutic agents. Cutis 78 (2006) 97-100
2. Crawford G.H., Pelle M.T., James W.D., and Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 51 (2004) 42-44 327-41; quiz
3. Wilkin J., Dahl M., Detmar M., Drake L., Feinstein A., Odom R., et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 46 (2002) 584-587
4. Wilkin J., Dahl M., Detmar M., Drake L., Liang M.H., Odom R., et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 50 (2004) 907-912
5. Takeda K., Kaisho T., Akira S., and Toll-like receptors. Ann Rev Immunol 21 (2003) 335-376
6. Meylan E., Tschopp Jr., and Karin M. Intracellular pattern recognition receptors in the host response. Nature 442 (2006) 39-44
7. Dorschner R.A., Pestonjamasp V.K., Tamakuwala S., Ohtake T., Rudisill J., Nizet V., et al. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 117 (2001) 91-97
8. Yamasaki K., Di Nardo A., Bardan A., Murakami M., Ohtake T., Coda A., et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 13 (2007) 975-980
9. De Y., Chen Q., Schmidt A.P., Anderson G.M., Wang J.M., Wooters J., et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 192 (2000) 1069-1074
10. Koczulla R., von Degenfeld G., Kupatt C., Krotz F., Zahler S., Gloe T., et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 111 (2003) 1665-1672
11. Gallo R.L., Ono M., Povsic T., Page C., Eriksson E., Klagsbrun M., et al. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc Natl Acad Sci USA 91 (1994) 11035-11039
12. Yamasaki K., Schauber J., Coda A., Lin H., Dorschner R.A., Schechter N.M., et al. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J 20 (2006) 2068-2080
13. Chen C.J., Kono H., Golenbock D., Reed G., Akira S., and Rock K.L. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 13 (2007) 851-856
14. Taylor K.R., Yamasaki K., Radek K.A., Di Nardo A., Goodarzi H., Golenbock D., et al. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J Biol Chem 282 (2007) 18265-18275
15. Schauber J., Dorschner R.A., Coda A.B., Buchau A.S., Liu P.T., Kiken D., et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 117 (2007) 803-811
16. Sneddon I. Perioral dermatitis. Br J Dermatol 87 (1972) 430-434
17. Weber G. Rosacea-like dermatitis: contraindication or intolerance reaction to strong steroids. Br J Dermatol 86 (1972) 253-259
18. Cotterill J.A. Perioral dermatitis. Br J Dermatol 101 (1979) 259-262
19. Wilkinson D.S., Kirton V., and Wilkinson J.D. Perioral dermatitis: a 12-year review. Br J Dermatol 101 (1979) 245-257
20. Shibata M., Katsuyama M., Onodera T., Ehama R., Hosoi J., and Tagami H. Glucocorticoids Enhance Toll-Like Receptor 2 Expression in Human Keratinocytes Stimulated with Propionibacterium acnes or Proinflammatory Cytokines. J Invest Dermatol (2008)
21. Sibenge S., and Gawkrodger D.J. Rosacea: a study of clinical patterns, blood flow, and the role of Demodex folliculorum. J Am Acad Dermatol 26 (1992) 590-593
22. Guzman-Sanchez D.A., Ishiuji Y., Patel T., Fountain J., Chan Y.H., and Yosipovitch G. Enhanced skin blood flow and sensitivity to noxious heat stimuli in papulopustular rosacea. J Am Acad Dermatol (2007)
23. Buechner S.A. Rosacea: an update. Dermatology 210 (2005) 100-108
24. Shanler S.D., and Ondo A.L. Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline. Arch Dermatol 143 (2007) 1369-1371
25. Gomaa A.H., Yaar M., Eyada M.M., and Bhawan J. Lymphangiogenesis and angiogenesis in non-phymatous rosacea. J Cutan Pathol 34 (2007) 748-753
26. 2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem 271 (1996) 21793-21797
27. Tokumaru S., Sayama K., Shirakata Y., Komatsuzawa H., Ouhara K., Hanakawa Y., et al. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol 175 (2005) 4662-4668
28. Tjabringa G.S., Aarbiou J., Ninaber D.K., Drijfhout J.W., Sorensen O.E., Borregaard N., et al. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol 171 (2003) 6690-6696
29. Detmar M., Brown L.F., Claffey K.P., Yeo K.T., Kocher O., Jackman R.W., et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180 (1994) 1141-1146
30. Miyachi Y., Yoshioka A., Imamura S., and Niwa Y. Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol 86 (1986) 449-453
31. Akamatsu H., Komura J., Asada Y., Miyachi Y., and Niwa Y. Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases. Arch Dermatol Res 283 (1991) 162-166
32. Akamatsu H., Oguchi M., Nishijima S., Asada Y., Takahashi M., Ushijima T., et al. The inhibition of free radical generation by human neutrophils through the synergistic effects of metronidazole with palmitoleic acid: a possible mechanism of action of metronidazole in rosacea and acne. Arch Dermatol Res 282 (1990) 449-454
33. Yoshioka A., Miyachi Y., Imamura S., and Niwa Y. Anti-oxidant effects of retinoids on inflammatory skin diseases. Arch Dermatol Res 278 (1986) 177-183
34. Bakar O., Demircay Z., Yuksel M., Haklar G., and Sanisoglu Y. The effect of azithromycin on reactive oxygen species in rosacea. Clin Exp Dermatol 32 (2007) 197-200
35. Jain A., Sangal L., Basal E., Kaushal G.P., and Agarwal S.K. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils. Dermatol Online J 8 (2002) 2
36. Bakar O., Yuksel Z.D.M., Haklar G., and Sanisoglu Y. The effect of azithromycin on reactive oxygen species in rosacea. Clin Exp Dermatol 32 (2007) 197-200
37. Peus D., Vasa R.A., Beyerle A., Meves A., Krautmacher C., and Pittelkow M.R. UVB activates ERK1/2 and p38 signaling pathways via reactive oxygen species in cultured keratinocytes. J Invest Dermatol 112 (1999) 751-756
38. 2 is an important mediator of UVB-induced EGF-receptor phosphorylation in cultured keratinocytes. J Invest Dermatol 110 (1998) 966-971
39. Young C.N., Koepke J.I., Terlecky L.J., Borkin M.S., Boyd S.L., and Terlecky S.R. Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease. J Invest Dermatol 128 (2008) 2606-2614
40. Lee H.M., Shin D.M., Kim K.K., Lee J.S., Paik T.H., and Jo E.K. Roles of Reactive oxygen species in CXCL8 and CCL2 expression in response to the 30-kDa antigen of mycobacterium tuberculosis. J Clin Immunol 29 (2009) 46-56
41. Yang C.S., Shin D.M., Lee H.M., Son J.W., Lee S.J., Akira S., et al. ASK1-p38 MAPK-p47phox activation is essential for inflammatory responses during tuberculosis via TLR2-ROS signalling. Cell Microbiol 10 (2008) 741-754
42. Kawaguchi Y., Tanaka H., Okada T., Konishi H., Takahashi M., Ito M., et al. The effects of ultraviolet A and reactive oxygen species on the mRNA expression of 72-kDa type IV collagenase and its tissue inhibitor in cultured human dermal fibroblasts. Arch Dermatol Res 288 (1996) 39-44
43. Bielenberg D.R., Bucana C.D., Sanchez R., Donawho C.K., Kripke M.L., and Fidler I.J. Molecular regulation of UVB-induced cutaneous angiogenesis. J Invest Dermatol 111 (1998) 864-872
44. Ballaun C., Weninger W., Uthman A., Weich H., and Tschachler E. Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J Invest Dermatol 104 (1995) 7-10
45. Longuet-Perret I., Schmitt D., and Viac J. Tumour necrosis factor-alpha is involved in the contrasting effects of ultraviolet B and ultraviolet A1 radiation on the release by normal human keratinocytes of vascular permeability factor. Br J Dermatol 138 (1998) 221-224
46. Naru E., Suzuki T., Moriyama M., Inomata K., Hayashi A., Arakane K., et al. Functional changes induced by chronic UVA irradiation to cultured human dermal fibroblasts. Br J Dermatol 153 Suppl 2 (2005) 6-12
47. Wlaschek M., Briviba K., Stricklin G.P., Sies H., and Scharffetter-Kochanek K. Singlet oxygen may mediate the ultraviolet A-induced synthesis of interstitial collagenase. J Invest Dermatol 104 (1995) 194-198
48. Scharffetter-Kochanek K., Wlaschek M., Briviba K., and Sies H. Singlet oxygen induces collagenase expression in human skin fibroblasts. FEBS Lett 331 (1993) 304-306
49. Lee Y., Kim H., Kim S., Shin M.H., Kim Y.K., Kim K.H., et al. Myeloid Differentiation Factor 88 Regulates Basal and UV-Induced Expressions of IL-6 and MMP-1 in Human Epidermal Keratinocytes. J Invest Dermatol 129 (2009) 460-467
50. Caubet C., Jonca N., Brattsand M., Guerrin M., Bernard D., Schmidt R., et al. Degradation of Corneodesmosome Proteins by Two Serine Proteases of the Kallikrein Family SCTE//KLK5//hK5 and SCCE//KLK7//hK7. J Invest Dermatol 122 (2004) 1235-1244
51. Descargues P., Deraison C., Prost C., Fraitag S., Mazereeuw-Hautier J., D'Alessio M., et al. Corneodesmosomal Cadherins Are Preferential Targets of Stratum Corneum Trypsin- and Chymotrypsin-like Hyperactivity in Netherton Syndrome. J Invest Dermatol 126 (2006) 1622-1632
52. Michael I.P., Sotiropoulou G., Pampalakis G., Magklara A., Ghosh M., Wasney G., et al. Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression. J Biol Chem 280 (2005) 14628-14635
53. Acharya M.R., Venitz J., Figg W.D., and Sparreboom A. Chemically modified tetracyclines as inhibitors of matrix metalloproteinases. Drug Resist Updat 7 (2004) 195-208
54. Sapadin A.N., and Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54 (2006) 258-265
55. Sorsa T., Lindy O., Konttinen Y.T., Suomalainen K., Ingman T., Saari H., et al. Doxycycline in the protection of serum alpha-1-antitrypsin from human neutrophil collagenase and gelatinase. Antimicrob Agents Chemother 37 (1993) 592-594
56. Joyce E., and Rundhaug. Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9 (2005) 267-285
57. Bonnar E., Eustace P., and Powell F.C. The Demodex mite population in rosacea. J Am Acad Dermatol 28 (1993) 443-448
58. Forton F., and Seys B. Density of Demodex folliculorum in rosacea: a case-control study using standardized skin-surface biopsy. Br J Dermatol 128 (1993) 650-659
59. Erbagci Z., and Ozgoztasi O. The significance of Demodex folliculorum density in rosacea. Int J Dermatol 37 (1998) 421-425
60. Lacey N., Delaney S., Kavanagh K., and Powell F.C. Mite-related bacterial antigens stimulate inflammatory cells in rosacea. Br J Dermatol 157 (2007) 474-481
61. Costa C.P., Kirschning C.J., Busch D., Durr S., Jennen L., Heinzmann U., et al. Role of chlamydial heat shock protein 60 in the stimulation of innate immune cells by Chlamydia pneumoniae. Eur J Immunol 32 (2002) 2460-2470
62. Gobert A.P., Bambou J.C., Werts C., Balloy V., Chignard M., Moran A.P., et al. Helicobacter pylori heat shock protein 60 mediates interleukin-6 production by macrophages via a toll-like receptor (TLR)-2-, TLR-4-, and myeloid differentiation factor 88-independent mechanism. J Biol Chem 279 (2004) 245-250
63. Rebora A., Drago F., and Picciotto A. Helicobacter pylori in patients with rosacea. Am J Gastroenterol 89 (1994) 1603-1604
64. Diaz C., O'Callaghan C.J., Khan A., and Ilchyshyn A. Rosacea: a cutaneous marker of Helicobacter pylori infection? Results of a pilot study. Acta Derm Venereol 83 (2003) 282-286
65. Argenziano G., Donnarumma G., Iovene M.R., Arnese P., Baldassarre M.A., and Baroni A. Incidence of anti-Helicobacter pylori and anti-CagA antibodies in rosacea patients. Int J Dermatol 42 (2003) 601-604
66. Szlachcic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol 16 (2002) 328-333
67. Jones M.P., Knable Jr. A.L., White M.J., and Durning S.J. Helicobacter pylori in rosacea: lack of an association. Arch Dermatol 134 (1998) 511
68. Gurer M.A., Erel A., Erbas D., Caglar K., and Atahan C. The seroprevalence of Helicobacter pylori and nitric oxide in acne rosacea. Int J Dermatol 41 (2002) 768-770
69. Utas S., Ozbakir O., Turasan A., and Utas C. Helicobacter pylori eradication treatment reduces the severity of rosacea. J Am Acad Dermatol 40 (1999) 433-435
70. Gedik G.K., Karaduman A., Sivri B., and Caner B. Has Helicobacter pylori eradication therapy any effect on severity of rosacea symptoms?. J Eur Acad Dermatol Venereol 19 (2005) 398-399
71. Boixeda de Miquel D., Vazquez Romero M., Vazquez Sequeiros E., Foruny Olcina J.R., Boixeda de Miquel P., Lopez San Roman A., et al. Effect of Helicobacter pylori eradication therapy in rosacea patients. Rev Esp Enferm Dig 98 (2006) 501-509
72. Ding S.Z., Minohara Y., Fan X.J., Wang J., Reyes V.E., Patel J., et al. Helicobacter pylori infection induces oxidative stress and programmed cell death in human gastric epithelial cells. Infect Immun 75 (2007) 4030-4039
73. Mashimo M., Nishikawa M., Higuchi K., Hirose M., Wei Q., Haque A., et al. Production of reactive oxygen species in peripheral blood is increased in individuals with Helicobacter pylori infection and decreased after its eradication. Helicobacter 11 (2006) 266-271
74. Bagchi D., Bhattacharya G., and Stohs S.J. Production of reactive oxygen species by gastric cells in association with Helicobacter pylori. Free Radic Res 24 (1996) 439-450
75. Baz K., Cimen M.Y., Kokturk A., Aslan G., Ikizoglu G., Demirseren D.D., et al. Plasma reactive oxygen species activity and antioxidant potential levels in rosacea patients: correlation with seropositivity to Helicobacter pylori. Int J Dermatol 43 (2004) 494-497
76. Kawahara T., Kuwano Y., Teshima-Kondo S., Kawai T., Nikawa T., Kishi K., et al. Toll-like receptor 4 regulates gastric pit cell responses to Helicobacter pylori infection. J Med Invest 48 (2001) 190-197
77. Smith Jr. M.F., Mitchell A., Li G., Ding S., Fitzmaurice A.M., Ryan K., et al. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem 278 (2003) 32552-32560